KakkarW.: Efficacy of Low Doses of Heparin in Prevention of Deep-Vein Thrombosis After Major Surgery, Lancet2: 101–106 (July 15) 1972.
2.
VerstraeteM.: Are Agents Affecting Platelet Functions Clinically Useful?, Am. J. Med.61: 897–914 (Dec.) 1976.
3.
WeissH. J.: Antiplatelet Drugs — A New Pharmacologic Approach to the Prevention of Thrombosis, Am. Heart J.92: 86–102 (July) 1976.
4.
GentonE.: Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease, N. Engl. J. Med.293: 1174–1178, 1236–1240, 1296–1300, 1975.
5.
MarcusA.: Aspirin and Thromboembolism — A Possible Dilemma, N. Engl. J. Med.297: 1284–1285 (Dec. 8) 1977.
6.
EvartsC. M.: Prevention of Thromboembolic Disease After Elective Surgery of the Hip, J. Bone Joint Surg.53-A: 1271–1280 (Oct.) 1971.
7.
The Canadian Cooperative Study Group: A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened Stroke, N. Engl. J. Med.299: 53–59 (July 13) 1978.
8.
Anturane® Reinfarction Trial Research Group: Sulfinpyrazone in the Prevention of Cardiac Death After Myocardial Infarction, N. Engl. J. Med.298: 289–295 (Feb. 9) 1978.
9.
SullivanJ. M.: Pharmacologic Control of Thromboembolic Complications of Cardiac-Valve Replacement, N. Engl. J. Med.279: 576–580 (Sept. 12) 1968.
10.
HarrisW. H.: Aspirin Prophylaxis of Venous Thromboembolism After Total Hip Replacement, N. Engl. J. Med.297: 1246–1249 (Dec. 8) 1977.
11.
MustardJ. F.: Function of Blood Platelets and Their Role in Thrombosis, Trans Am. Clin. Climatol. Assoc.87: 104–127, 1976.
